Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$62M |
 |
Mind Medicine (MindMed)MNMD |
-$44M |
 |
ModernaMRNA |
-$265B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Holzer Phil M | Nov 4, 2024 | Sell | 700 | $55.615 | $39,000 |
| Hirawat Samit | Nov 1, 2024 | Buy | 1,830 | $54.675 | $100,000 |
| BOERNER CHRISTOPHER S. | Dec 5, 2023 | Buy | 2,000 | $49.78 | $100,000 |
| BOERNER CHRISTOPHER S. | Nov 28, 2023 | Buy | 3,071 | $48.86 | $150,000 |
| Samuels Theodore R. II | Nov 20, 2023 | Buy | 8,500 | $49.81 | $420,000 |
| Powell Ann | Aug 24, 2023 | Sell | 17,986 | $61.25 | $1.1M |
| Plenge Robert M | Aug 3, 2023 | Sell | 732 | $61.14 | $45,000 |
| VESSEY RUPERT | May 3, 2023 | Sell | 50,385 | $67.06 | $3.4M |
| Caforio Giovanni | Feb 6, 2023 | Sell | 240,000 | $74.65 | $18M |
| Powell Ann | Feb 6, 2023 | Sell | 11,183 | $74.69 | $840,000 |
What's the latest insider transaction for Bristol-Myers Squibb?
The most recent insider transaction for Bristol-Myers Squibb was conducted by Holzer Phil M, who sold 700 shares on November 4, 2024 at a price of $55.62 per share.
Which insider bought the most BMY stock over the last two years?
Samuels Theodore R. II has bought the most BMY stock in the last 2 years, with a total value of $420,000.
Which insider has sold the most BMY stock over the last two years?
Caforio Giovanni has sold the most BMY stock in the last 2 years, with a total value of $18M.
What is the total value of insider transactions for Bristol-Myers Squibb (BMY) in the last 2 years?
The total value of insider transactions for Bristol-Myers Squibb in the last 2 years is negative, amounting to -$23M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Bristol-Myers Squibb's market confidence?
Over the last 2 years, insider transactions for Bristol-Myers Squibb have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
